JPY8,024.00
2.01%
Tokyo, Sep 13, 08:15 am CET
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Otsuka Stock price

JPY8,024.00
+114.00 1.44% 1M
+2,018.00 33.60% 6M
+2,735.00 51.71% YTD
+2,612.00 48.26% 1Y
+3,081.00 62.33% 3Y
+3,322.00 70.65% 5Y
+4,358.00 118.88% 10Y
Tokyo, Closing price Fri, Sep 13 2024
-165.00 2.01%
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Key metrics

Market capitalization JPY4.36t
Enterprise Value JPY4.16t
P/E (TTM) P/E ratio 34.34
EV/FCF (TTM) EV/FCF 20.08
EV/Sales (TTM) EV/Sales 1.91
P/S ratio (TTM) P/S ratio 2.00
P/B ratio (TTM) P/B ratio 1.66
Dividend yield 1.50%
Last dividend (FY24) JPY120.00
Revenue growth (TTM) Revenue growth 16.50%
Revenue (TTM) Revenue JPY2.18t
EBIT (operating result TTM) EBIT JPY341.95b
Free Cash Flow (TTM) Free Cash Flow JPY207.31b
Cash position JPY485.89b
EPS (TTM) EPS JPY233.68
P/E forward 19.18
P/S forward 1.90
EV/Sales forward 1.82
Show more

Is Otsuka a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Otsuka Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Otsuka forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Otsuka forecast:

Buy
70%
Hold
30%

Financial data from Otsuka

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
589,412 589,412
18% 18%
100%
- Direct Costs 164,409 164,409
9% 9%
28%
425,003 425,003
22% 22%
72%
- Selling and Administrative Expenses 212,633 212,633
23% 23%
36%
- Research and Development Expense 71,561 71,561
3% 3%
12%
140,809 140,809
40% 40%
24%
- Depreciation and Amortization 27,338 27,338
17% 17%
5%
EBIT (Operating Income) EBIT 113,471 113,471
47% 47%
19%
Net Profit 30,418 30,418
26% 26%
5%

In millions JPY.

Don't miss a Thing! We will send you all news about Otsuka directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Tatsuo Higuchi
Employees 34,388
Founded 1921
Website www.otsuka.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today